annb0t
Top 20
ResMed Inc.
New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates.
88.7 million new COPD hospitalizations projected across Western Europe between 2019 - 2050 Vaping projected to incur almost â¬30 billion additional direct and indirect costs by 2050 â¬4.9 trillion projected c...
>>> Read more: Vaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non-Invasive Ventilation (NIV) enhancing survival rates.
88.7 million new COPD hospitalizations projected across Western Europe between 2019 - 2050 Vaping projected to incur almost â¬30 billion additional direct and indirect costs by 2050 â¬4.9 trillion projected c...
>>> Read more: Vaping Expected to Increase COPD Health and Economic Burden by 2050
